SLC2A1 and Hyperglycemia: Evidence suggests that chronic hyperglycemia in patients with DM causes the body to form a self‐protection mechanism, preferentially down‐regulating glucose transporters (GLUT‐1 and GLUT‐3), allowing glucose to enter cells independently of insulin, thus reducing the acute fluctuation of glucose concentration and reducing endothelial cell apoptosis.62